Mogenet, Alice
Finetti, Pascal
Denicolai, Emilie
Greillier, Laurent
Boudou-Rouquette, Pascaline
Goldwasser, François
Lumet, Gwenael
Ceccarelli, Michele
Birnbaum, Daniel
Bedognetti, Davide
Mamessier, Emilie
Barlesi, Fabrice
Bertucci, François http://orcid.org/0000-0002-0157-0959
Tomasini, Pascale
Article History
Received: 24 July 2023
Accepted: 22 August 2023
First Online: 19 September 2023
Declarations
:
: This study was approved by our institutional review board under the number 2019_93. All patients had given their signed written informed consent for the use of archived material for research purpose. The in silico analysis was based upon public data from published studies in which the informed patient's consent to participate and the ethics and institutional review board were already obtained by authors.
: Not applicable.
: A Mogenet received consulting fees from Takeda, Viatris and Pfizer and travel fees from BMS and Pfizer. The other authors have declared no competing interests.